An outbreak of severe invasive meningococcal disease due to a capsular switched Neisseria meningitidis hypervirulent strain B:cc11.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 06 06 2018
revised: 13 07 2018
accepted: 16 07 2018
pubmed: 24 7 2018
medline: 26 4 2019
entrez: 24 7 2018
Statut: ppublish

Résumé

The aim was to investigate an outbreak of invasive meningococcal disease (IMD) in Southern Sardinia. Epidemiological and microbiological investigations were performed. The latter included antimicrobial susceptibility testing and whole-genome sequencing (WGS). Seven individuals with severe IMD were found to be infected with serogroup B (MenB) Neisseria meningitidis in the first quarter of 2018. Five of the seven cases (five males; mean age 19 years; range 18-21 years; CFR 40%) were due to a unique strain B:P1.5-1,10-8:F3-6:ST-11(cc11), probably switched from the hypervirulent C-cc11, as confirmed by WGS. All five patients had attended the same nightclub in the 2 weeks prior to symptom onset. Public health measures, including chemoprophylaxis of contacts and active immunization against MenB, were implemented. We observed five IMD cases due to the same switched MenB strain. The hypervirulent B:P1.5-1,10-8:F3-6:ST-11(cc11) strain, probably switched from C-cc11, is of concern due to the observed high virulence and case fatality rates. All the patients shared the same place of probable exposure. The molecular characterization of the invasive strain allowed the outbreak to be confirmed, which was then controlled through timely public health action.

Identifiants

pubmed: 30036673
pii: S1198-743X(18)30532-9
doi: 10.1016/j.cmi.2018.07.014
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antigens, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111.e1-111.e4

Informations de copyright

Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

P Stefanelli (P)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: paola.stefanelli@iss.it.

C Fazio (C)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

P Vacca (P)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

A Palmieri (A)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

L Ambrosio (L)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

A Neri (A)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

A Piana (A)

Department of Medical Surgical and Experimental Sciences, University Hospital of Sassari, Italy.

P Castiglia (P)

Department of Medical Surgical and Experimental Sciences, University Hospital of Sassari, Italy.

F Argiolas (F)

Servizio promozione della salute e osservatorio epidemiologico, Assessorato dell'Igiene e Sanità e dell'assistenza sociale-Regione Autonoma della Sardegna, Italy.

S Santus (S)

Public Health Service, Local Health Unit, Cagliari, Italy.

L Masala (L)

Laboratory SS Trinità Hospital, Sardinian Health Service, Italy.

G Steri (G)

Public Health Service, Local Health Unit, Cagliari, Italy.

F Riccardo (F)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

S Iannazzo (S)

Director General for Health Prevention, Ministry of Health, Rome, Italy.

F P Maraglino (FP)

Director General for Health Prevention, Ministry of Health, Rome, Italy.

C D'Amario (C)

Director General for Health Prevention, Ministry of Health, Rome, Italy.

G Rezza (G)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH